Edited by: Thomas W. Durso
D.J. Lenschow, S.C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K.C. Herold, J.A. Bluestone, "Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse," Journal of Experimental Medicine, 181:1145-55, 1995 (Cited in more than 100 papers as of April 1997)
Comments by Jeffrey A. Bluestone, Ben May Institute, University of Chicago
ONE OR THE OTHER: Jeffrey Bluestone of the University of Chicago helped discover which of two costimulatory molecules is important in the progression of autoimmune diabetes.